Therapeutic Challenges in Metastatic Non-small Cell Lung Cancer (NSCLC) With Concurrent Mesenchymal-Epithelial Transition Factor (MET) Amplification and High Programmed Death-Ligand 1 (PD-L1) Expression: A Case Study.

albumin-bound paclitaxel - Generic mfg.

pemetrexed - Generic mfg.

Tecentriq (atezolizumab) - Roche

carboplatin - Generic mfg.

Tabrecta (capmatinib) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42802808

Arman Reza Chowdhury; Hasin Mesbah Bin Siddique; Masud Parvez; Md Arifur Rahman; Mohammad S Faisal

Sep 29, 2026